London: The UKThe U.S. health regulator has approved vaccines from Pfizer and AstraZeneca for booster doses against COVID-19, even as the country’s decision on a third dose is pending.
“We know that a person’s Immunity may decrease over time after their first Vaccination Period. I am pleased to confirm that the COVID-19 vaccines made by Pfizer and AstraZeneca can be used as a safe and effective booster dose,” said Jun Raine, Chief Executive of the MHRA Medicines and Healthcare Products Regulatory Agency (MHA). MHRA) said in a statement on Thursday. .
The decision has been made after a careful review of available data on the safety and effectiveness of booster or supplemental vaccine doses by the MHRA and the Independent Commission on Human Medicines (CHM), which advises the government.
The MHRA also noted that it is now up to the UK vaccine advisory body, the Joint Committee on Immunization and Immunization (JCVI), “to advise whether booster jabs will be given and, if so, which vaccines to be used.” should go”.
JCVI is awaiting the results of seven different booster vaccines, which are expected this week. However, the JCVI states that a third dose should be offered to people with severely weakened immune systems, which are about half a million people over the age of 12 in the UK.
Earlier this week, ministers said the National Health Service (NHS) was ready to go if booster jabs were given the go-ahead.
But AstraZeneca chief Pascal Soriot warned against rushing into a nationwide rollout, saying it could put additional pressure on the company.
The nation’s already burdened NHS.
Writing in The Telegraph, he said a third dose of vaccines against COVID-19 may not be needed for everyone in the UK.
In addition, the decision to capture the entire population “should be based on real-world clinical effectiveness data, not just”
Antibody measurement”, Soriot wrote in the newspaper.
On the other hand, Albert Boerla, CEO of American pharmaceutical company Pfizer, said that covid Those receiving the vaccine will “likely” need a third dose between six and 12 months after being fully vaccinated.
He also suggested the need for annual vaccination against coronavirus. The US is also expected to soon introduce COVID booster vaccines for all its citizens, even as the World Health Organization has called for a moratorium on the boosters.
The US has already started the third dose for immunocompromised people. Other countries that have introduced booster vaccines include Israel, Italy, France and Russia.
“We know that a person’s Immunity may decrease over time after their first Vaccination Period. I am pleased to confirm that the COVID-19 vaccines made by Pfizer and AstraZeneca can be used as a safe and effective booster dose,” said Jun Raine, Chief Executive of the MHRA Medicines and Healthcare Products Regulatory Agency (MHA). MHRA) said in a statement on Thursday. .
The decision has been made after a careful review of available data on the safety and effectiveness of booster or supplemental vaccine doses by the MHRA and the Independent Commission on Human Medicines (CHM), which advises the government.
The MHRA also noted that it is now up to the UK vaccine advisory body, the Joint Committee on Immunization and Immunization (JCVI), “to advise whether booster jabs will be given and, if so, which vaccines to be used.” should go”.
JCVI is awaiting the results of seven different booster vaccines, which are expected this week. However, the JCVI states that a third dose should be offered to people with severely weakened immune systems, which are about half a million people over the age of 12 in the UK.
Earlier this week, ministers said the National Health Service (NHS) was ready to go if booster jabs were given the go-ahead.
But AstraZeneca chief Pascal Soriot warned against rushing into a nationwide rollout, saying it could put additional pressure on the company.
The nation’s already burdened NHS.
Writing in The Telegraph, he said a third dose of vaccines against COVID-19 may not be needed for everyone in the UK.
In addition, the decision to capture the entire population “should be based on real-world clinical effectiveness data, not just”
Antibody measurement”, Soriot wrote in the newspaper.
On the other hand, Albert Boerla, CEO of American pharmaceutical company Pfizer, said that covid Those receiving the vaccine will “likely” need a third dose between six and 12 months after being fully vaccinated.
He also suggested the need for annual vaccination against coronavirus. The US is also expected to soon introduce COVID booster vaccines for all its citizens, even as the World Health Organization has called for a moratorium on the boosters.
The US has already started the third dose for immunocompromised people. Other countries that have introduced booster vaccines include Israel, Italy, France and Russia.
.